# An expanded 75-color panel of Pdots for spectral multiplexing

> **NIH NIH R44** · LAMPROGEN, INC. · 2024 · $499,583

## Abstract

Project Summary
Flow cytometry is widely used in basic and translational research and in clinical diagnostic assays. Spectral flow
cytometry represents a revolutionary change in the approach to flow cytometry by using full spectral information
from each fluorophore—by collecting the emission over the full spectrum and using multiple excitation sources
for each fluorophore to obtain a spectral “signature” or “fingerprint”. The resulting spectral signature is used in
automated spectral unmixing that is simpler and more effective than current compensation methods. As a result,
even fluorophores with highly overlapping spectra can be used simultaneously, simplifying panel construction
and enlarging the maximum panel size; subtraction of cell autofluorescence is also improved. These factors
combine to allow greater resolution of cell subpopulations. In addition, hardware can be simplified since a
particular configuration of filter sets is not needed for a particular set of dyes. Spectral flow cytometry has
progressed to the mainstream, with several commercial spectral flow systems now available (Cytek Aurora, Sony
ID7000, BD Symphony A5 SE, Thermo Bigfoot).
However, the development of dyes has not kept pace with the development of spectral flow systems. For
example, Sony’s ID7000 system includes a 320 nm excitation source for which no dyes have been specifically
developed. We and others have developed a new family of ultrabright fluorescent nanoparticles called Pdots,
which are semiconducting polymers collapsed into 5–30 nm (tunable size) nanoparticles. Pdots are bright and
photostable, and are unique in exhibiting a long, tunable Stokes shift, enabling the creation of a large color panel.
Here we propose to expand the multi-color panel of Pdots from 37 to 75 by adding 38 new colors,
including a new series of 18 Pdots excited at 320 nm (no previous Pdots have been excitable at 320 nm), as
well as 20 new Pdots excited at 355, 405, 488, 561, and 640 nm, filling gaps between the emission peaks of
existing Pdots with the same excitation while preserving a separation of at least 20 nm between emission peaks
with most emission peaks separated by 30 nm or larger. We will demonstrate the utility of these Pdots in spectral
flow cytometry by developing and validating a 75-parameter panel for deep immunophenotyping of major cell
subsets in human peripheral blood. The 75-color panel of Pdots will also be useful in high multiplex tissue
imaging (e.g., histopathology).

## Key facts

- **NIH application ID:** 10897281
- **Project number:** 5R44GM151936-02
- **Recipient organization:** LAMPROGEN, INC.
- **Principal Investigator:** Jiangbo Yu
- **Activity code:** R44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $499,583
- **Award type:** 5
- **Project period:** 2023-08-01 → 2025-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10897281

## Citation

> US National Institutes of Health, RePORTER application 10897281, An expanded 75-color panel of Pdots for spectral multiplexing (5R44GM151936-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10897281. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*